Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05155176 · ClinicalTrials.gov registry record
Novel Real-world Methods in Social Drinkers and AUD
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 54
- Enrollment target
NCT05155176: Completed study, sponsored by Yale University.
NCT05155176 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05155176 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
This research project proposes a novel approach to elucidate the biological adaptations associated with Alcohol Use Disorder and to assess whether such adaptations are predictive of higher alcohol craving in response to both alcohol cues and stressors and higher relapse risk and alcohol use in the real world.
Primary Outcome
Participants will report using ecological momentary assessment (EMA) their current levels of craving, if they have drank alcohol, and if they experienced a stressor. These reports will be generated in three different ways: at 8 am and 8 pm at night, at four random times during waking hours, and while drinking alcohol. Individuals with AUD will be compared to social drinkers in their differences in real-world ratings of stress and craving. Craving and stress will be assessed using a 100-point vis
Interventions
- BEHAVIORAL Intensive Day Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2022-05-01 |
| Est. Completion | 2023-12-31 |
What the finished NCT05155176 record still lists
NCT05155176 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Intensive Day Monitoring is the first listed.
NCT05155176 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05155176 about?
NCT05155176 is a clinical study titled "Novel Real-world Methods in Social Drinkers and AUD". This research project proposes a novel approach to elucidate the biological adaptations associated with Alcohol Use Disorder and to assess whether such adaptations are predictive of higher alcohol craving in response to both alcohol cues and stressors and higher relapse risk and alcohol use in the r...
What is the current status of trial NCT05155176?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2022-05-01. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05155176?
The interventions under investigation include: Intensive Day Monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT05155176?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI